KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scansource (SCSC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Scansource (SCSC) over the last 17 years, with Q4 2025 value amounting to $2.0 million.

  • Scansource's Capital Expenditures rose 5.07% to $2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.3 million, marking a year-over-year increase of 333.37%. This contributed to the annual value of $8.3 million for FY2025, which is 314.44% down from last year.
  • According to the latest figures from Q4 2025, Scansource's Capital Expenditures is $2.0 million, which was up 5.07% from $2.4 million recorded in Q3 2025.
  • In the past 5 years, Scansource's Capital Expenditures ranged from a high of $3.5 million in Q2 2022 and a low of $80000.0 during Q2 2021
  • For the 5-year period, Scansource's Capital Expenditures averaged around $1.9 million, with its median value being $2.1 million (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first plummeted by 7842.83% in 2021, then skyrocketed by 430375.0% in 2022.
  • Scansource's Capital Expenditures (Quarter) stood at $1.6 million in 2021, then soared by 61.13% to $2.5 million in 2022, then increased by 1.8% to $2.5 million in 2023, then decreased by 22.56% to $2.0 million in 2024, then grew by 0.05% to $2.0 million in 2025.
  • Its Capital Expenditures was $2.0 million in Q4 2025, compared to $2.4 million in Q3 2025 and $2.5 million in Q2 2025.